Lawan Larsuprom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lawan Larsuprom has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chalermpol Lekcharoensuk
Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand
1 shared publication - Chantima Pruksakorn
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Rd., Bangkok 10900, Thailand
1 shared publication Charles Chen
Asian Veterinary Specialist Referral Center, 1F No.109 Section 4 Xin Yi road, Taipei, Taiwan
1 shared publicationNutchaphon Rungroj
Department of Microbiology and Immunology, Kasetsart University, 50 Ngamwongwan Road, Chatuchak, Bangkok, 10900, Thailand
1 shared publicationSumet Kongkiatpaiboon
Drug Discovery and Development Center, Thammasat University (Rangsit Campus), Pathumthani, 12121, Thailand
1 shared publicationUdomlak Sukatta
Department of Microbiology and Immunology, Kasetsart University, 50 Ngamwongwan Road, Chatuchak, Bangkok, 10900, Thailand
1 shared publication
Latest Publications
- 22 August 2019
- Published by Wiley in Veterinary Dermatology
- Vol. 30 (6) , 487-+
In vitro antibacterial activity of mangosteen (Garcinia mangostana Linn.) crude extract against Staphylococcus pseudintermedius isolates from canine pyoderma
Background: Staphylococcus pseudintermedius, commonly involved in canine pyoderma, can be classified as meticillin‐susceptible S. pseudintermedius (MSSP) or meticillin‐resistant S. pseudintermedius (MRSP). MRSP infections may be difficult to treat due to broad β‐lactam resistance of MRSP and typically additional multidrug‐resistance. Topical antibacterial treatment is the preferred treatment modality for surface and superficial skin infections.Hypothesis⁄objectives: Mangosteen crude extract containing the antibacterial compound α‐mangostin will have in vitro activity against MSSP and MRSP isolated from canine pyoderma.Bacterial isolates: Twenty‐three samples, MSSP (n = 12) and MRSP (n = 11), isolated from canine pyoderma.Methods and materials: Minimum inhibitory concentrations (MICs) were determined for mangosteen crude extract by broth microdilution. High‐performance liquid chromatography (HPLC) analysis was used to determine the amount of α‐mangostin in mangosteen crude extract. A time‐kill assay was performed at 30 min and 2 h after exposure to a high concentration of crude extract (100× MIC). Antibacterial activity for α‐mangostin was calculated according to HPLC results.Results: The concentration of α‐mangostin was 17.72 ± 1.42% w/w. The mean MIC of α‐mangostin towards MSSP was 0.53 ± 0.35 μg/mL, whereas the mean value for MRSP was 0.47 ± 0.27 μg/mL. There was no difference between the mean MIC of MRSP and MSSP (P = 0.84). After a 30 min exposure to 100× MIC of the crude extract, a 95% reduction in colony forming units was found.Conclusions and clinical importance: The results showed that α‐mangostin in mangosteen crude extract was effective in inhibiting S. pseudintermedius (both MRSP and MSSP). Clinical studies are needed to investigate this effectiveness further in vivo.
- 22 August 2019
- Published by Wiley in Veterinary Dermatology
- Vol. 30 (6) , 487-+
In vitro antibacterial activity of mangosteen (Garcinia mangostana Linn.) crude extract against Staphylococcus pseudintermedius isolates from canine pyoderma
Background: Staphylococcus pseudintermedius, commonly involved in canine pyoderma, can be classified as meticillin‐susceptible S. pseudintermedius (MSSP) or meticillin‐resistant S. pseudintermedius (MRSP). MRSP infections may be difficult to treat due to broad β‐lactam resistance of MRSP and typically additional multidrug‐resistance. Topical antibacterial treatment is the preferred treatment modality for surface and superficial skin infections.Hypothesis⁄objectives: Mangosteen crude extract containing the antibacterial compound α‐mangostin will have in vitro activity against MSSP and MRSP isolated from canine pyoderma.Bacterial isolates: Twenty‐three samples, MSSP (n = 12) and MRSP (n = 11), isolated from canine pyoderma.Methods and materials: Minimum inhibitory concentrations (MICs) were determined for mangosteen crude extract by broth microdilution. High‐performance liquid chromatography (HPLC) analysis was used to determine the amount of α‐mangostin in mangosteen crude extract. A time‐kill assay was performed at 30 min and 2 h after exposure to a high concentration of crude extract (100× MIC). Antibacterial activity for α‐mangostin was calculated according to HPLC results.Results: The concentration of α‐mangostin was 17.72 ± 1.42% w/w. The mean MIC of α‐mangostin towards MSSP was 0.53 ± 0.35 μg/mL, whereas the mean value for MRSP was 0.47 ± 0.27 μg/mL. There was no difference between the mean MIC of MRSP and MSSP (P = 0.84). After a 30 min exposure to 100× MIC of the crude extract, a 95% reduction in colony forming units was found.Conclusions and clinical importance: The results showed that α‐mangostin in mangosteen crude extract was effective in inhibiting S. pseudintermedius (both MRSP and MSSP). Clinical studies are needed to investigate this effectiveness further in vivo.